Featuring 9 tracks of programming, the MIXiii BIOMED 2020 Conference invites attendees to explore what’s next in the worlds of Biotechnology and Life Sciences.
18th National Life Sciences & Technology Week
May 14 – 16, 2019 | David InterContinental Tel Aviv, Israel
17th National Life Sciences & Technology Week
May 15 – 17, 2018 | David InterContinental Tel Aviv, Israel
16th National Life Science & Technology Week
Robert Cohen
VP of Global R&D, Chief Technology Officer, Stryker Joint Replacement
Amy Schulman
Managing Partner, Polaris Partners
Prof. Robert Langer
Institute Professor at MIT, MIT Department of Chemical Engineering
Andrew “Cal” Callaway
Managing Director, U.S. Healthcare Investment Banking, Royal Bank of Canada (RBC)
Prof. Yitshak Kreiss, MD
Director General, Sheba Medical Center
Aharon Aharon
CEO, Israel Innovation Authority (IIA)
Eric H. Rubin MD
Senior VP, Global Clinical Oncology, Merck & Co
Jeremy M. Levin, DPhil, MB BChir
CEO and Chairman, Ovid Therapeutics
Robotics Role in Future Healthcare Systems
Chair: Ori Hadomi
VP New Business Development & Partnerships, Medtronic
Longevity – How to Die Young at a Very Old Age
Co-Chairs: Anat Naschitz
Managing Director, OrbiMed Advisors
Nir Barzilai, MD
Rennert Professor of Aging, Albert Einstein College of Medicine
Yael Benvenisti, PhD
CEO, Mediterranean Towers Ventures
Next Generation BioTherapeutics – Gene Editing, RNAi, Oligos, Cell and Gene Therapies, Microbiome and others
Co-Chairs: Yaron Carmi, PhD
Assistant Professor, Sackler School of Medicine, Tel Aviv University
Jonathan Solomon
CEO, BiomX
AI Technology Redefining the Future of Biopharma, Care Delivery, and Holistic Medicine
Co-Chairs: Iris Grossman, PhD
Chief Scientific Officer, Camp4 Therapeutics
Tamara Mansfeld
Global Innovation Lead, Digital Innovation Lab, Pfizer
Decoding the Brain Enigma: Parkinson, Alzheimer’s, ALS, Mental Disorders
Co-Chairs: Barry Greene
President, Alnylam Pharmaceuticals
Dekel Taliaz, PhD
Co-Founder and CEO, Taliaz
Bright Spots Illuminating the Future of Medical Devices
Co-chairs: Irit Yaniv, MD
Managing Partner, Accelmed Ventures Fund
James Eadie, MD
Partner, Santé Ventures
Targeted Cancer Treatment; Cure? Maintenance? – Has Medicine Reached these Points?
Chair: Prof. David Sidransky, MD,
Johns Hopkins School of Medicine; Co-Founder & General Partner, Israel Biotech Fund
Exact and Biological Science Diagnostics – Sensors, Genomics, AI, Imaging, and others
Co-Chairs: Prof. Varda Shalev, MD, MPA
Head, KSM Kahn – Sagol – Maccabi Research & Innovation Institute
Yair Schindel, MD
Managing Partner & Co-Founder, aMoon Fund
Bio-convergence – Biologically Inspired Engineering Reshaping Future Medicine
Federico Goodsaid, PhD
Ex-FDA & Senior VP Regulatory Affairs, Ariana Pharma
Dimitris Agrafiotis, PhD
Chief Information Officer, Novartis Institutes for BioMedical Research (NIBR)
Rosana Kapeller-Libermann, PhD
EIR, Google Ventures
Daphna Laifenfeld, PhD
Chief Strategy Officer, Ibex Medical Analytics
Michal Ozery-Flato, PhD
Machine Learning Researcher, IBM Haifa Research Lab
Eric de La Fortelle, PhD
Venture Partner, Seventure
Pierre Belichard
CEO, Enterome
Jeremy M. Levin, DPhil, MB BChir
CEO and Chairman, Ovid Therapeutics
Prof. Amir Lerman, MD
Cardiovascular Diseases and Internal Medicine, Mayo Clinic
Prof. Tamar Flash, PhD
Department of Computer Science and Applied Mathematics, Weizmann Institute of Science
Wenbo Liu
Co-Founder & Chief Technology Officer, Sinovation (Beijing) Medical Technology Co., LTD
Allitia DiBernardo, MD
Global Medical Affairs Lead, Neurosciences, The Janssen Pharmaceutical Companies of Johnson & Johnson
Prof. Peter A. Noseworthy, MD
Department of Cardiovascular Medicine, Mayo Clinic
Miro Venturi, PhD, MSc
Senior Vice President & Head, Biopharma, Foundation Medicine
Barry Greene
President, Alnylam Pharmaceuticals
Laura Lande-Diner, PhD
Director of Innovation, Integral Health
Hakan Sakul, PhD
Vice President and Head of Diagnostics, Pfizer Inc, Worldwide R&D – La Jolla Laboratories
Richard Kendall, PhD
CEO, ImmPACT Bio Inc
Megan Rosengarten
VP / General Manager, Surgical Robotics, Medtronic
Mehmood Khan
Chief Executive Officer Life, Biosciences
Steve Austad, PhD
Distinguished Professor and Chair of the Department of Biology, University of Alabama at Birmingham
James Peyer, PhD
Founder and Managing Partner, Kronos BioVentures
Joan Mannick, MD
Chief Medical Officer, resTORbio
Zan Fleming, MD
Founder and Executive Chairman, Kinexum
Rafael de Cabo, PhD
Senior Investigator, Translational Gerontology Branch, NIH
Prof. Eran Segal, PhD
Department of Computer Science and Applied Math, Weizmann Institute
Michael Alonso, PhD
VP of Immunology & Pharmacology & Co-Founder, Bolt Biotherapeutics
George Daniel Demetri, MD
Director, Ludwig Center, Dana-Farber/Harvard Cancer Center
Johan Luthman
Executive VP, R&D, H. Lundbeck A/S
Devi Prasad Shetty, MBBS, MS, FRCS
Chairman & Founder, Narayana Health
Gary Gershony, MD, FACC, FSCAI, FAHA, FRCPC
Director of Cardiovascular Research, Education & Technology, John Muir Health Cardiovascular Institute; Life Science Angels – Medical Device & Digital Health Committee
John J. Smith, MD, JD
Partner, Hogan Lovells
The conference serves as a meeting point for local and multinational companies, venture capitalists, private equity investors, corporate and institutional investors, technology transfer experts, licensing executives, business development executives, university, government and corporate research scientists and government representatives.
